Medicago's New Drug Submission Accepted for Scientific Review by Health Canada: an Important ...

Quebec City, Oct. 2, 2019 /CNW Telbec/ - Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters in Quebec City, announces that Health Canada accepted for scientific review its New Drug Submission (NDS) for a plant-based Quadrivalent Virus-Like Particle (QVLP) influenza recombinant vaccine."This is an important step on the road to commercialization", said Dr. Bruce Clark, President...This story is related to the following:Vaccines
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news